InsidersTradesSigma
Track the 에스바이오메딕스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 에스바이오메딕스 has published 4 public disclosures. Market capitalisation: €244.6bn. The latest transaction was filed on 31 August 2026 (Sale). Among the most active insiders: KANG SAEIL. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Listed on the XKRX market, 에스바이오메딕스 specializes in the health and pharmaceutical sector. The company focuses on developing innovative medical solutions.